Peptide inhibitor of Japanese encephalitis virus infection targeting envelope protein domain III
- 1 April 2014
- journal article
- research article
- Published by Elsevier BV in Antiviral Research
- Vol. 104, 7-14
- https://doi.org/10.1016/j.antiviral.2014.01.011
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Japanese encephalitis virus interacts with vimentin to facilitate its entry into porcine kidney cell lineVirus Research, 2011
- Phage Display of Combinatorial Peptide Libraries: Application to Antiviral ResearchMolecules, 2011
- Structural Optimization and De Novo Design of Dengue Virus Entry Inhibitory PeptidesPLoS Neglected Tropical Diseases, 2010
- Heat shock protein 70 on Neuro2a cells is a putative receptor for Japanese encephalitis virusVirology, 2008
- Antiviral Peptides Targeting the West Nile Virus Envelope ProteinJournal of Virology, 2007
- The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entryMicrobes and Infection, 2006
- Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoproteinJournal of General Virology, 2005
- Virus Attachment and Entry Offer Numerous Targets for Antiviral TherapyCurrent Pharmaceutical Design, 2004
- Blocking the dengue virus 2 infections on BHK-21 cells with purified recombinant dengue virus 2 E protein expressed in Escherichia coliBiochemical and Biophysical Research Communications, 2003
- Biophysical Characterization and Vector-Specific Antagonist Activity of Domain III of the Tick-Borne Flavivirus Envelope ProteinJournal of Virology, 2001